ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Bioqual Inc (PK)

Bioqual Inc (PK) (BIOQ)

75.00
0.00
(0.00%)
Closed April 19 4:00PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
75.00
Bid
51.00
Ask
200.00
Volume
-
0.00 Day's Range 0.00
59.00 52 Week Range 82.00
Market Cap
Previous Close
75.00
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
367
Shares Outstanding
894,416
Dividend Yield
0.67%
PE Ratio
80.33
Earnings Per Share (EPS)
0.93
Revenue
62.66M
Net Profit
835k

About Bioqual Inc (PK)

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Bioqual Inc (PK) is listed in the Coml Physical, Biologcl Resh sector of the OTCMarkets with ticker BIOQ. The last closing price for Bioqual (PK) was $75. Over the last year, Bioqual (PK) shares have traded in a share price range of $ 59.00 to $ 82.00.

Bioqual (PK) currently has 894,416 shares outstanding. The market capitalization of Bioqual (PK) is $67.08 million. Bioqual (PK) has a price to earnings ratio (PE ratio) of 80.33.

BIOQ Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
4-2-2.597402597477777563675CS
1234.1666666666772807036774.58564815CS
261627.118644067859805930273.45242537CS
52-7-8.5365853658582825954869.18088652CS
156-10.75-12.536443148785.75108.55750979.00382881CS
26039108.33333333336108.52858762.78053916CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TWGTop Wealth Group Holding Ltd
$ 3.73
(101.62%)
36.49M
CSLRComplete Solaria Inc
$ 0.465319
(75.59%)
16.55M
SHOTWSafety Shot Inc
$ 0.48
(60.00%)
6.71k
EGOXNext e GO NV
$ 0.0515
(43.06%)
332.89M
MNDRMobile health Network Solutions
$ 27.2386
(33.72%)
10.26M
YYAIConnexa Sports Technologies Inc
$ 0.8943
(-57.21%)
13.39M
SBFMSunshine Biopharma Inc
$ 1.77
(-46.69%)
11.89M
GTIGraphjet Technology
$ 6.43
(-33.09%)
95.33k
ISPCiSpecimen Inc
$ 0.2883
(-31.52%)
2.86M
BGLCBioNexus Gene Lab Corporation
$ 0.5998
(-29.32%)
735.31k
EGOXNext e GO NV
$ 0.0515
(43.06%)
332.89M
SQQQProShares UltraPro Short QQQ
$ 12.84
(6.38%)
219.71M
AGBAAGBA Group Holding Ltd
$ 1.255
(21.84%)
128.73M
TQQQProShares UltraPro QQQ
$ 49.48
(-6.20%)
125.32M
SINTSiNtx Technologies Inc
$ 0.0414
(3.50%)
109.4M

BIOQ Discussion

View Posts
AskMuncher AskMuncher 4 years ago
$BIOQ BIOQUAL Presents Financial Results for Fiscal Year 2020 and Declares Dividend
Press Release | 09/15/2020
BIOQUAL ((OTC Pink: BIOQ) (www.bioqual.com):



2020




2019




Revenue

$

46,360,201


$

39,478,079




Income Before Income Tax

$

5,488,938


$

3,709,246




Net Income

$

4,230,938


$

2,830,875




Basic Earnings per Share








of Common Stock

$

4.74


$

3.17


Diluted Earnings per Share








of Common Stock

$

4.73


$

3.17


Weighted Average








Number of Shares Outstanding






For Basic Per Share



893,416




893,416


Weighted Average








Number of Shares Outstanding






For Diluted Earnings Per Share



893,971




893,655

BIOQUAL’s Board of Directors has declared a dividend of $1.10 per share for shareholders of record on September 28, 2020, payable on October 21, 2020. This is the nineteenth dividend declared by BIOQUAL.

Statements herein that are not descriptions of historical facts are forward-looking and subject to risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors including risks relating to the ability to continue to extend current government contracts; the Company’s ability to obtain new government or commercial contracts; continued demand for the use of animal models in scientific research; the Company’s ability to perform under its contracts in accordance with the requirements of the contracts; the actual costs incurred in performing the Company’s contracts and its ability to manage its costs, including its capital expenditures; dependence on third parties; future capital needs; the ability to fund its capital needs through the use of its cash on hand and line of credit; and the future availability and cost of financing/capital sources to the Company.


View source version on businesswire.com: https://www.businesswire.com/news/home/20200915005969/en/
👍️0
Ubertino Ubertino 9 years ago
Get on a decent exchange!

Too easily to manipulate as an OTC-Pinky!

Get on a decent exchange - NYSE or affiliate - then I might be interested.
👍️0

Your Recent History

Delayed Upgrade Clock